ConductScience.org, home

Paper38136164

A Multitarget Approach against Neuroinflammation: Alkyl Substituted Coumarins as Inhibitors of Enzymes Involved in Neurodegeneration.

Berrino E and 13 others. Antioxidants (Basel), 2023. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. A Multitarget Approach against Neuroinflammation: Alkyl Substituted Coumarins as Inhibitors of Enzymes Involved in Neurodegeneration. Papers, record 38136164. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38136164

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A Multitarget Approach against Neuroinflammation: Alkyl Substituted Coumarins as Inhibitors of Enzymes Involved in Neurodegeneration.
PubMed
Journal
Antioxidants (Basel)
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
2.38
iCite
Revised in PubMed
2023-12-25
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Berrino EEmanuelahttps://orcid.org/0000-0002-4258-0678
2Carradori SSimonehttps://orcid.org/0000-0002-8698-9440
3Carta FFabriziohttps://orcid.org/0000-0002-1141-6146
4Melfi FFrancesco
5Gallorini MMarialuciahttps://orcid.org/0000-0002-2283-4159
6Poli GGiulio
7Tuccinardi TTizianohttps://orcid.org/0000-0002-6205-4069
8Fernández-Bolaños JGJosé G
9López ÓÓscar
10Petzer JPJacobus P
11Petzer AAnél
12Guglielmi PPaolo
13Secci DDaniela
14Supuran CTClaudiu Thttps://orcid.org/0000-0003-4262-0323

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References92

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129936084The many faces of partial inhibition: Revealing imposters with graphical analysis.Arch Biochem Biophys2018https://conductscience.org/library/papers/29936084PubMed
232714977Multitarget Therapeutic Strategies for Alzheimer's Disease: Review on Emerging Target Combinations.Biomed Res Int2020https://conductscience.org/library/papers/32714977PubMed
337848673Ferroptosis: underlying mechanisms and involvement in neurodegenerative diseases.Apoptosis2024https://conductscience.org/library/papers/37848673PubMed
427830812Ageing, neurodegeneration and brain rejuvenation.Nature2016https://conductscience.org/library/papers/27830812PubMed
525820651Indanones as high-potency reversible inhibitors of monoamine oxidase.ChemMedChem2015https://conductscience.org/library/papers/25820651PubMed
637543158Antidepressant effects of coumarins and their derivatives: A critical analysis of research advances.Eur J Pharmacol2023https://conductscience.org/library/papers/37543158PubMed
736829773On the Chemical and Biological Characteristics of Multifunctional Compounds for the Treatment of Parkinson's Disease.Antioxidants (Basel)2023https://conductscience.org/library/papers/36829773PubMed
832779543Coumarin carbonic anhydrase inhibitors from natural sources.J Enzyme Inhib Med Chem2020https://conductscience.org/library/papers/32779543PubMed
922687539Inhibitory effects of 6-alkoxycoumarin and 7-alkoxycoumarin derivatives on lipopolysaccharide/interferon γ-stimulated nitric oxide production in RAW264 cells.Biol Pharm Bull2012https://conductscience.org/library/papers/22687539PubMed
1030530106Combined molecular modeling and cholinesterase inhibition studies on some natural and semisynthetic O-alkylcoumarin derivatives.Bioorg Chem2019https://conductscience.org/library/papers/30530106PubMed
1137488838Type-B monoamine oxidase inhibitors in neurological diseases: clinical applications based on preclinical findings.Neural Regen Res2024https://conductscience.org/library/papers/37488838PubMed
1236698238A Review on the Natural Components Applied as Lead Compounds for Potential Multi-target Anti-AD Theranostic Agents.Curr Med Chem2023https://conductscience.org/library/papers/36698238PubMed
1337242434Antioxidant Activity of Coumarins and Their Metal Complexes.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/37242434PubMed
1432035016The role of astrocytes in oxidative stress of central nervous system: A mixed blessing.Cell Prolif2020https://conductscience.org/library/papers/32035016PubMed
1520131845New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.J Med Chem2010https://conductscience.org/library/papers/20131845PubMed
1612563284Neurobiology of butyrylcholinesterase.Nat Rev Neurosci2003https://conductscience.org/library/papers/12563284PubMed
1732695817Multitarget Therapeutics for Neurodegenerative Diseases.Biomed Res Int2020https://conductscience.org/library/papers/32695817PubMed
1830123107Regulation of IL-6 Secretion by Astrocytes via TLR4 in the Fragile X Mouse Model.Front Mol Neurosci2018https://conductscience.org/library/papers/30123107PubMed
1937833901Pharmacological Modulation of Oxidative Stress.Int J Mol Sci2023https://conductscience.org/library/papers/37833901PubMed
2013843767A rapid spectrophotometric assay of mono-amine oxidase based on the rate of disappearance of kynuramine.J Biol Chem1960https://conductscience.org/library/papers/13843767PubMed

See all 92 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
42796509Coumarin Compounds with 6- or 7-(4-Aminobutynyloxy) Substituent: Synthesis, In Vitro Cytotoxicity and In Silico DNA Binding Studies.Molecules2026https://conductscience.org/library/papers/42796509PubMed
42062767Future Directions in Biotechnological and Pharmacological Applications of CAIs.Subcell Biochem2026https://conductscience.org/library/papers/42062767PubMed
41781781Current advances in 7-hydroxycoumarin derivatives as potential therapeutic agents for Alzheimer's disease.Mol Divers2026https://conductscience.org/library/papers/41781781PubMed
41502372Hybridization Approach Applied to Umbelliferon and Vanilloids toward New Inhibitors of Carbonic Anhydrases IX and XII with In Vitro Antiproliferative and Anti-inflammatory Activities.J Med Chem2026https://conductscience.org/library/papers/41502372PubMed
40635213Potential of MAO-B Inhibitors with Multi-target Inhibition and Antioxidant Properties for the Treatment of Neurodegenerative Disorders.Mini Rev Med Chem2026https://conductscience.org/library/papers/40635213PubMed
40573227Multitarget Compounds Designed for Alzheimer, Parkinson, and Huntington Neurodegeneration Diseases.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40573227PubMed
40453177Design, synthesis, molecular modelling investigation and biological studies of novel human carbonic anhydrase inhibitors based on coumalic acid.RSC Med Chem2025https://conductscience.org/library/papers/40453177PubMed
40153574Inflammatory Bridges: Interconnections Between Alzheimer's Disease and Bone Health.Aging Dis2025https://conductscience.org/library/papers/40153574PubMed
40005200Playing Around the Coumarin Core in the Discovery of Multimodal Compounds Directed at Alzheimer's-Related Targets: A Recent Literature Overview.Molecules2025https://conductscience.org/library/papers/40005200PubMed
39942697In Vitro CO-Releasing and Antioxidant Properties of Sulfonamide-Based CAI-CORMs in a H2O2-Stimulated Human Achilles Tendon-Derived Cell Model.Molecules2025https://conductscience.org/library/papers/39942697PubMed
39398983Coumarin: A natural solution for alleviating inflammatory disorders.Curr Res Pharmacol Drug Discov2024https://conductscience.org/library/papers/39398983PubMed
39124919Naturally Inspired Coumarin Derivatives in Alzheimer's Disease Drug Discovery: Latest Advances and Current Challenges.Molecules2024https://conductscience.org/library/papers/39124919PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACHE43PubTator's text mininghttps://conductscience.org/library/genes/43NCBI Gene
BCHE590PubTator's text mininghttps://conductscience.org/library/genes/590NCBI Gene
HCA1266790PubTator's text mininghttps://conductscience.org/library/genes/266790NCBI Gene
MAOA4128PubTator's text mininghttps://conductscience.org/library/genes/4128NCBI Gene
MAOB4129PubTator's text mininghttps://conductscience.org/library/genes/4129NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38136164

GET https://conductscience.org/api/papers/v1/38136164/references?page=2